A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT04305197 · COMPLETED

Trial details

NCT number: NCT04305197
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2020-07-09
Primary completion: 2022-04-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.